Milena Sant, MD EPAAC WP9 leader Descriptive Studies and Health Planning Unit Istituto Nazionale Tumori, Milano, Italy EUROPEAN HIGH RESOLUTION STUDY 6th.
ADCC
HERCEPTIN Herceptin [trastuzumab] Foundation of care in women with HER2-positive breast cancer Update 2010 Herceptin Small Tumor Efficacy is consistent.
Prepared by Dr. Ammar C. Al-Rikabi & Dr. Ghassan Zidan
Carlos L. Arteaga, M.D. Departments of Medicine and Cancer Biology Breast Cancer Research Program Vanderbilt Ingram Comprehensive Cancer Center Vanderbilt.
Prepared by Dr. Ammar C. Al-Rikabi & Dr. Ghassan Zidan.
Welcome! Please take a moment to complete the short in your packet. Your participation will help us assess the effectiveness of this program and shape.
![HERCEPTIN Herceptin [trastuzumab] Foundation of care in women with HER2-positive breast cancer Update 2010 Herceptin Small Tumor Efficacy is consistent.](https://static.fdocuments.us/doc/330x215/56649d2d5503460f94a04a57/herceptin-herceptin-trastuzumab-foundation-of-care-in-women-with-her2-positive.jpg)
